Stock Earnings

Question 1

What are Janux Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Janux Therapeutics Inc has a total asset of $1,062, Net loss of $-68

Question 2

What are the key financial ratios for JANX?

Accepted Answer

Janux Therapeutics Inc's Current ratio is 27.23, has a Net margin is -680, sales per share of $0.18.

Question 3

How is Janux Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Janux Therapeutics Inc largest revenue segment is Novel Immunotherapies, at a revenue of 10,588,000 in the most earnings release.For geography, United States is the primary market for Janux Therapeutics Inc, at a revenue of 10,588,000.

Question 4

Is Janux Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Janux Therapeutics Inc has a net loss of $-68

Question 5

Does Janux Therapeutics Inc have any liabilities?

Accepted Answer

yes, Janux Therapeutics Inc has liability of 39

Question 6

How many outstanding shares for Janux Therapeutics Inc?

Accepted Answer

Janux Therapeutics Inc has a total outstanding shares of 59

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	10	10	8	8	3	0
Revenue Growth (YoY)	-23%	25%	0%	167%	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	39	41	26	22	10	1
Research & Development	115	68	54	53	26	3
Operating Expenses	154	109	81	75	36	4
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-101	-68	-58	-63	-32	-6
Income Tax Expense	--	--	--	--	--	--
Net Income	-101	-68	-58	-63	-32	-6
Net Income Growth	68%	17%	-8%	97%	433%	50%
Shares Outstanding (Diluted)	62.02	53.75	44.01	41.47	41.62	39.9
Shares Change (YoY)	14%	22%	6%	0%	4%	0%
EPS (Diluted)	-1.64	-1.28	-1.32	-1.52	-0.78	-0.17
EPS Growth	49%	-3%	-13%	95%	359%	70%
Free Cash Flow	-71	-44	-52	-49	-18	-4
Free Cash Flow Per Share	-1.14	-0.81	-1.18	-1.18	-0.43	-0.1
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,440%	-980%	-900%	-837.5%	-1,066.66%	0%
Profit Margin	-1,010%	-680%	-725%	-787.5%	-1,066.66%	0%
Free Cash Flow Margin	-710%	-440%	-650%	-612.5%	-600%	0%
EBITDA	-142	-96	-71	-67	-32	-4
EBITDA Margin	-1,420%	-960%	-887.5%	-837.5%	-1,066.66%	0%
D&A For EBITDA	2	2	1	0	0	0
EBIT	-144	-98	-72	-67	-32	-4
EBIT Margin	-1,440%	-980%	-900%	-837.5%	-1,066.66%	0%
Effective Tax Rate	--	--	--	--	--	--

Janux Therapeutics Inc (JANX) Price

JANX Stock Price Chart

JANX Income

Follow-Up Questions